Omnipod® 5 and FreeStyle Libre 2 Plus – Fuel Your Freedom
Omnipod 5 is a tubeless automated insulin delivery (AID) system, also known as a hybrid closed loop system (HCL), to integrate with the FreeStyle Libre 2 Plus glucose monitor for people living with type 1 diabetes, aged 2 and above.
Simplified diabetes management personalised to your unique daily insulin needs.
Omnipod 5 - a simpler way to manage your diabetes
Enjoy the benefits of increased time in range and reduced A1c* with the Omnipod 5 Automated Insulin Delivery System.
Our tubeless, discreet, waterproof‡ Pod is worn directly on the body to give you precise, automated insulin delivery for up to three days (72 hours).
The Pod has made Omnipod a wearable alternative to traditional insulin pumps for years.
Now we’ve made it automated!
FreeStyle Libre 2 Plus - The convenience of a 15-day sensor
Expanded access: For people with diabetes who prefer the FreeStyle Libre brand, starting on Omnipod 5 can be simple, making tubeless automated insulin delivery easy to access
How does the FreeStyle Libre 2 Plus work?
The FreeStyle Libre 2 Plus sensor measures glucose levels at regular intervals using a sensor inserted just under the skin.
If you are interested in finding out more about the FreeStyle Libre 2 Plus Sensor, please click the link below and speak to your healthcare professional. Please refer to the manufacture user guide for full instructions for use
Omnipod 5 and FreeStyle Libre 2 Plus: Powerful integration to revolutionize diabetes management
Using our algorith technology, Omnipod 5 and FreeStyle Libre 2 Plus work together in constant communication as part of an Automated Insulin Delivery (AID) system, also known as a Hybrid Closed Loop (HCL) system.
The system smoothly responds to predicted glucose levels by automatically increasing, decreasing or pausing insulin delivery depending on whether glucose levels are rising or falling.
Here’s what our Podders have to say about Omnipod® 5
Omnipod 5 has allowed me to get a good night sleep. That's the first time I can say that in a long time.
Alvin
Podder since 2017
It helps me feel like a normal kid, just with a little bit of help.
Romey T.
Sponsored Podder®
With Omnipod 5, I’ve found a new confidence that I didn’t have before… I feel like a new person. Omnipod 5 makes me feel safe.
Morgan M.
Podder®
*Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average day time (6AM-12AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.8% vs. 72.5%; 51.5% vs. 64.6%. Average overnight (12AM-6AM) in Target Glucose range (from CGM) in adults/adolescents and children for standard therapy vs Omnipod 5 = 64.3% vs. 78.1%; 55.3% vs. 78.1%. Average A1c in adults/adolescents and children, standard therapy vs. Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%. Brown et al. Diabetes Care (2021).
‡The Pod has a waterproof IP28 rating for up to 7.6 metres for up to 60 minutes. The Omnipod® 5 Controller is not waterproof. Please refer to Sensor manufacturer user guide for Sensor waterproof rating
§ Fingerpricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Source for FreeStyle Libre 2 Plus information : https://www.freestyle.abbott/uk-en/products/freestyle-libre-2-plus-Sensor.html
Data on file, Abbott Diabetes Care, Inc.
Haak, T. Diabetes Therapy (2017): https://doi.org/10.1007/s13300-016-0223-6.
Leelarathna, L. N Engl J Med. (2022): DOI: 10.1056/NEJMoa2205650.
Yaron, M. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166.
For children aged 2-12, a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre 2 system and interpreting its readings.
† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.
Intended Purpose as per Instructions for Use for The Omnipod 5 Automated Insulin Delivery System :
The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin. The Omnipod 5 System is intended to operate as an automated insulin delivery system when used with compatible Continuous Glucose Monitors (CGM). When in Automated Mode, the Omnipod 5 System is designed to assist people with type 1 diabetes in achieving glycaemic targets set by their healthcare providers. It is intended to modulate (increase, decrease or suspend) insulin delivery to operate within predefined threshold values using current and predicted sensor glucose values to maintain blood glucose at variable target glucose levels, thereby reducing glucose variability. This reduction in variability is intended to lead to a reduction in the frequency, severity, and duration of both hyperglycaemia and hypoglycaemia. The Omnipod 5 System can also operate in a Manual Mode that delivers insulin at set or manually adjusted rates. The Omnipod 5 System is intended for single patient use.The Omnipod 5 System is indicated for use with U-100 rapid acting insulin.
Warning: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over delivery or under-delivery of insulin, which could lead to hypoglycaemia or hyperglycaemia.